Suppr超能文献

[重症新型冠状病毒肺炎患者的姑息治疗]

[Palliation in patients with severe COVID-19].

作者信息

Ekström Magnus, Dahlander Bengt

机构信息

.

överläkare, Capio ASiH/SPSV Nacka.

出版信息

Lakartidningen. 2020 Apr 3;117:F3PM.

Abstract

Coronavirus Disease 2019 (COVID-19) can cause severe respiratory failure and distressing symptoms including fever, cough, breathlessness and anxiety. Symptomatic (palliative) treatment is of fundamental importance both in conjuncture with life-sustaining interventions and in end of life care. Based on the evidence to date, there are several treatment options to consider for the relief of fever (acetaminophen, NSAID, oral glucocorticoids), cough (morphine), breathlessness (morphine, oxygen, fan), anxiety (benzodiazepines) and pain (NSAID, morphine). Top priorities include precautions to protect staff and people at-risk from infection and planning how to provide adequate treatment for each individual depending on setting, including palliative care.

摘要

2019冠状病毒病(COVID-19)可导致严重呼吸衰竭,并伴有发热、咳嗽、呼吸急促和焦虑等令人痛苦的症状。对症(姑息)治疗在与维持生命的干预措施相结合以及临终关怀中都至关重要。根据迄今为止的证据,有几种治疗方法可供考虑用于缓解发热(对乙酰氨基酚、非甾体抗炎药、口服糖皮质激素)、咳嗽(吗啡)、呼吸急促(吗啡、氧气、风扇)、焦虑(苯二氮䓬类药物)和疼痛(非甾体抗炎药、吗啡)。首要任务包括采取预防措施保护工作人员和高危人群免受感染,以及根据不同环境规划如何为每个人提供充分治疗,包括姑息治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验